Cefepime + Taniborbactam

Synonym(s): VNRX-5133  |  VNX5133

Class: Beta-lactam + beta-lactamase inhibitor (boronate)

Spectrum of activity:	Gram-negative
Details of activity:	Active against Enterobacteriaceae and Psuedomonas aeruginosa
Institute where first reported:	VenatoRx Pharmaceuticals, USA
Highest developmental phase:	Phase 3
Development status:	Active (as of 2024)

Chemical structure(s):
Canonical SMILES:	C1=CC(=C2C(=C1)C[C@@H](B(O)O2)NC(=O)CC3CCC(CC3)NCCN)C(=O)O
Isomeric SMILES:	B1([C@H](CC2=C(O1)C(=CC=C2)C(=O)O)NC(=O)CC3CCC(CC3)NCCN)O
InChI:	InChI=1S/C19H28BN3O5/c21-8-9-22-14-6-4-12(5-7-14)10-17(24)23-16-11-13-2-1-3-15(19(25)26)18(13)28-20(16)27/h1-3,12,14,16,22,27H,4-11,21H2,(H,23,24)(H,25,26)/t12?,14?,16-/m0/s1
InChI Key:	PFZUWUXKQPRWAL-PXCJXSSVSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/76902493

External links:
Guide to Pharmacology:	taniborbactam
Main Source:	https://aac.asm.org/content/64/3/e01963-19